Business Context and Reporting Period
This Form 8-K Current Report was filed by Nephros, Inc. on April 27, 2017, regarding events occurring on that date and effective May 1, 2017. The filing addresses Item 5.02, concerning the appointment of certain officers and compensatory arrangements.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation adjustments.
Material Changes
The primary material change reported is the modification of the employment terms for Andrew Astor, the Company's Chief Financial Officer:
- Employment Status: Increased from part-time to full-time, effective May 1, 2017.
- Base Salary: Annualized base salary increased to $250,000, effective May 1, 2017.
- Equity Grant: Granted a 10-year stock option to purchase 418,709 shares of common stock under the 2015 Equity Incentive Plan.
- Exercise Price: $0.293 per share (closing sale price on the grant date).
Guidance, Outlook, and Vesting Conditions
While no forward-looking financial guidance is provided, the stock option grant includes specific performance-based vesting conditions that serve as implicit operational targets:
- Time-Based Vesting: 12.5% vests on the first anniversary; 37.5% vests in quarterly installments starting three months after the first anniversary.
- Market Listing Milestone: 20% vests upon approval of listing on NASDAQ, NYSE, or another approved national securities exchange.
- Revenue Milestones:
- 10% vests on February 1 following the first fiscal year with annual revenue exceeding $6,000,000.
- 20% vests on February 1 following the first fiscal year with annual revenue exceeding $10,000,000.
Investor Verification Checklist
- Verify the current trading status of Nephros, Inc. common stock to assess the likelihood of the 20% vesting condition tied to a national exchange listing.
- Review recent financial statements to determine the company's current revenue trajectory relative to the $6 million and $10 million vesting thresholds.
- Confirm the total number of shares authorized under the 2015 Equity Incentive Plan to assess dilution impact from this grant.
- Check for any subsequent filings regarding Mr. Astor's continued employment status.